XBiotech(XBIT)
AUSTIN, TXBiotechnology
Focus: XBiotech is a 5,000+ person public biotech company focused on antibody therapeutics for immunology and oncology, headquartered in Austin, TX. The company operates as a clinical-stage developer with multiple Phase 1–2 programs and limited commercial revenue.
Profile data last refreshed 23h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Employees
5000+
Total Funding
$2.5M
Open Jobs
0
About XBiotech
AI assessmentNot HiringNo open roles listed right now. Follow XBiotech to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from XBiotech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Hutrukin
PharmacokineticsClinical Trials (1)
NCT05098080Hutrukin to Analyze Safety and PK in Healthy Volunteers
Phase 1Help build intelligence for XBiotech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.